DE69120021D1 - Anwendung von Makrophagen Kolonie-stumulierendem Faktor in der Behandlung von Cachexia - Google Patents

Anwendung von Makrophagen Kolonie-stumulierendem Faktor in der Behandlung von Cachexia

Info

Publication number
DE69120021D1
DE69120021D1 DE69120021T DE69120021T DE69120021D1 DE 69120021 D1 DE69120021 D1 DE 69120021D1 DE 69120021 T DE69120021 T DE 69120021T DE 69120021 T DE69120021 T DE 69120021T DE 69120021 D1 DE69120021 D1 DE 69120021D1
Authority
DE
Germany
Prior art keywords
stumbling
cachexia
factor
treatment
macrophage colony
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69120021T
Other languages
English (en)
Inventor
Gideon Strassmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69120021D1 publication Critical patent/DE69120021D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69120021T 1990-11-01 1991-10-22 Anwendung von Makrophagen Kolonie-stumulierendem Faktor in der Behandlung von Cachexia Expired - Lifetime DE69120021D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/607,693 US5087453A (en) 1990-11-01 1990-11-01 Method for the treatment of bacterial caused weight loss and/or hypoglycemia

Publications (1)

Publication Number Publication Date
DE69120021D1 true DE69120021D1 (de) 1996-07-11

Family

ID=24433310

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120021T Expired - Lifetime DE69120021D1 (de) 1990-11-01 1991-10-22 Anwendung von Makrophagen Kolonie-stumulierendem Faktor in der Behandlung von Cachexia

Country Status (4)

Country Link
US (1) US5087453A (de)
EP (1) EP0483643B1 (de)
JP (1) JPH04270225A (de)
DE (1) DE69120021D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030203006A1 (en) * 1997-10-29 2003-10-30 Ajinomoto Co. Inc. Immunomodulator
US6197749B1 (en) 1997-10-29 2001-03-06 Ajinomoto Co., Inc. Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes
EP1158989B1 (de) * 1999-03-09 2007-06-20 Anker, Stefan Endotoxinhemmern zur behandlung von kachexie
US7247618B2 (en) * 2001-04-30 2007-07-24 Tripathi Rajavashisth Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
JPH0764742B2 (ja) * 1985-11-27 1995-07-12 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド Aids型疾患治療用組成物
US4879111A (en) * 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4868119A (en) * 1986-12-11 1989-09-19 Genetics Institute, Inc. Hematopoietic growth factors
US4879227A (en) * 1986-05-06 1989-11-07 Genetics Institute, Inc. Production of a recombinant human colony stimulating factor
US4916118A (en) * 1986-08-18 1990-04-10 Board Of Regents, The University Of Texas System Pharmaceutical administration systems containing chemotactic peptides
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
US4808402A (en) * 1987-05-29 1989-02-28 Northwestern University Method and compositions for modulating neovascularization
ATE213950T1 (de) * 1987-09-22 2002-03-15 Chiron Corp Verwendung von rekombinantem koloniestimulierendem faktor-1 zur herstellung eines medikaments gegen cytomegalovirusinfektionen
DK54589A (da) * 1988-02-08 1989-08-09 Otsuka Pharma Co Ltd Humane kolonistmulerende faktorer
WO1990001942A1 (en) * 1988-08-19 1990-03-08 Genetics Institute, Inc. Treatment for malignant melanoma

Also Published As

Publication number Publication date
JPH04270225A (ja) 1992-09-25
EP0483643B1 (de) 1996-06-05
EP0483643A3 (en) 1992-07-08
EP0483643A2 (de) 1992-05-06
US5087453A (en) 1992-02-11

Similar Documents

Publication Publication Date Title
ATE110556T1 (de) Verbesserungen bei der behandlung von zähnen.
DE69530860D1 (de) Behandlung der entzündung des sehnervs
IT1230485B (it) Particelle fini di poliorganosilsesquiossano e procedimento per produrre le stesse
DE69312853D1 (de) Behandlung von Gummiartikeln
BR9105087A (pt) Composicao aquosa geleificavel e utilizacao
DE69333659D1 (de) Einschätzung von in trans-agierenden faktoren der allelen variation
DE69316203D1 (de) Elektrochemische behandlung von oberflächen
EP0278173A3 (en) Use of heterocyclic derivatives in the treatment of depressions
DE69128383D1 (de) Oberflächenbehandlung und beschichtung von formkörpern
DE69327742D1 (de) Holzbehandlungsverfahren
DE59107445D1 (de) Kombination von Arbeitsgerät und höhenverstellbare Versorgungseinheit
DE69221617D1 (de) Aufbereitung von flüssigkeit
DE69132054D1 (de) Behandlung von windelausschlag
DE69525349D1 (de) Behandlung von sclaganfall mit einer infiltration von makrophagen assoziiert
DE69132782D1 (de) Verwendung von angiotensin-ii-antagonisten in der behandlung der linken ventrikulären hypertrophie
DE69120021D1 (de) Anwendung von Makrophagen Kolonie-stumulierendem Faktor in der Behandlung von Cachexia
DE69104961D1 (de) Anwendung von Thiazolylalkoxyacrylaten in der Herstellung von Insektiziden und/oder Akanizide-Zusammensetzungen.
DE69125175D1 (de) Verwendung von angiotensin-ii-rezeptorantagonisten bei der behandlung von atheromen
DE69115649D1 (de) Isotaktisches Polyglycidylnitrat und Herstellung desselben
ATE142503T1 (de) Arzneimittelzubereitung bei der behandlung von tonsillitis
EP0453658A3 (en) Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases
DE69202895D1 (de) Feuchtmittelzusatz und Anwendung desselben.
DE69306831D1 (de) Behandlung von Flüssigkeiten
DE69115602D1 (de) Haarbehandlungszusammensetzung
DE69333241D1 (de) Reinigung von faktor ix

Legal Events

Date Code Title Description
8332 No legal effect for de